These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30797866)

  • 1. Single-domain antibody fusion proteins can target and shuttle functional proteins into macrophage mannose receptor expressing macrophages.
    De Vlaeminck Y; Lecocq Q; Giron P; Heirman C; Geeraerts X; Bolli E; Movahedi K; Massa S; Schoonooghe S; Thielemans K; Goyvaerts C; Van Ginderachter JA; Breckpot K
    J Control Release; 2019 Apr; 299():107-120. PubMed ID: 30797866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments.
    Blykers A; Schoonooghe S; Xavier C; D'hoe K; Laoui D; D'Huyvetter M; Vaneycken I; Cleeren F; Bormans G; Heemskerk J; Raes G; De Baetselier P; Lahoutte T; Devoogdt N; Van Ginderachter JA; Caveliers V
    J Nucl Med; 2015 Aug; 56(8):1265-71. PubMed ID: 26069306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Translation of [
    Xavier C; Blykers A; Laoui D; Bolli E; Vaneyken I; Bridoux J; Baudhuin H; Raes G; Everaert H; Movahedi K; Van Ginderachter JA; Devoogdt N; Caveliers V; Lahoutte T; Keyaerts M
    Mol Imaging Biol; 2019 Oct; 21(5):898-906. PubMed ID: 30671739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages.
    Movahedi K; Schoonooghe S; Laoui D; Houbracken I; Waelput W; Breckpot K; Bouwens L; Lahoutte T; De Baetselier P; Raes G; Devoogdt N; Van Ginderachter JA
    Cancer Res; 2012 Aug; 72(16):4165-77. PubMed ID: 22719068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of [
    Bala G; Baudhuin H; Remory I; Gillis K; Debie P; Krasniqi A; Lahoutte T; Raes G; Devoogdt N; Cosyns B; Hernot S
    Mol Imaging Biol; 2018 Apr; 20(2):260-267. PubMed ID: 28875290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages.
    Ye J; Yang Y; Dong W; Gao Y; Meng Y; Wang H; Li L; Jin J; Ji M; Xia X; Chen X; Jin Y; Liu Y
    Int J Nanomedicine; 2019; 14():3203-3220. PubMed ID: 31118632
    [No Abstract]   [Full Text] [Related]  

  • 7. SPECT imaging of joint inflammation with Nanobodies targeting the macrophage mannose receptor in a mouse model for rheumatoid arthritis.
    Put S; Schoonooghe S; Devoogdt N; Schurgers E; Avau A; Mitera T; D'Huyvetter M; De Baetselier P; Raes G; Lahoutte T; Matthys P
    J Nucl Med; 2013 May; 54(5):807-14. PubMed ID: 23447654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting Manipulated Small Extracellular Vesicles to Subvert Immunosuppression at the Tumor Microenvironment through Mannose Receptor/CD206 Targeting.
    Fiani ML; Barreca V; Sargiacomo M; Ferrantelli F; Manfredi F; Federico M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mannose receptor (MR) engagement by mesothelin GPI anchor polarizes tumor-associated macrophages and is blocked by anti-MR human recombinant antibody.
    Dangaj D; Abbott KL; Mookerjee A; Zhao A; Kirby PS; Sandaltzopoulos R; Powell DJ; Lamazière A; Siegel DL; Wolf C; Scholler N
    PLoS One; 2011; 6(12):e28386. PubMed ID: 22163010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Size-advantage of monovalent nanobodies against the macrophage mannose receptor for deep tumor penetration and tumor-associated macrophage targeting.
    Erreni M; D'Autilia F; Avigni R; Bolli E; Arnouk SM; Movahedi K; Debie P; Anselmo A; Parente R; Vincke C; van Leeuwen FWB; Allavena P; Garlanda C; Mantovani A; Doni A; Hernot S; Van Ginderachter JA
    Theranostics; 2023; 13(1):355-373. PubMed ID: 36593955
    [No Abstract]   [Full Text] [Related]  

  • 11. Macrophage mannose receptor-specific gene delivery vehicle for macrophage engineering.
    Ruan GX; Chen YZ; Yao XL; Du A; Tang GP; Shen YQ; Tabata Y; Gao JQ
    Acta Biomater; 2014 May; 10(5):1847-55. PubMed ID: 24440421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors.
    Bolli E; D'Huyvetter M; Murgaski A; Berus D; Stangé G; Clappaert EJ; Arnouk S; Pombo Antunes AR; Krasniqi A; Lahoutte T; Gonçalves A; Vuylsteke M; Raes G; Devoogdt N; Movahedi K; Van Ginderachter JA
    J Control Release; 2019 Nov; 314():1-11. PubMed ID: 31626860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Protumoral Tumor-Associated Macrophages with Nanobody-Functionalized Nanogels through Strain Promoted Azide Alkyne Cycloaddition Ligation.
    Nuhn L; Bolli E; Massa S; Vandenberghe I; Movahedi K; Devreese B; Van Ginderachter JA; De Geest BG
    Bioconjug Chem; 2018 Jul; 29(7):2394-2405. PubMed ID: 29889515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular imaging of tumor-infiltrating macrophages in a preclinical mouse model of breast cancer.
    Sun X; Gao D; Gao L; Zhang C; Yu X; Jia B; Wang F; Liu Z
    Theranostics; 2015; 5(6):597-608. PubMed ID: 25825599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotherapeutic target or sink: analysis of the macrophage mannose receptor tissue distribution in murine models of lysosomal storage diseases.
    Zhang XS; Brondyk W; Lydon JT; Thurberg BL; Piepenhagen PA
    J Inherit Metab Dis; 2011 Jun; 34(3):795-809. PubMed ID: 21416197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of mannosylated enzyme and the mannose receptor in enzyme replacement therapy.
    Du H; Levine M; Ganesa C; Witte DP; Cole ES; Grabowski GA
    Am J Hum Genet; 2005 Dec; 77(6):1061-74. PubMed ID: 16380916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide.
    Scodeller P; Simón-Gracia L; Kopanchuk S; Tobi A; Kilk K; Säälik P; Kurm K; Squadrito ML; Kotamraju VR; Rinken A; De Palma M; Ruoslahti E; Teesalu T
    Sci Rep; 2017 Nov; 7(1):14655. PubMed ID: 29116108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The function of cancer-shed gangliosides in macrophage phenotype: involvement with angiogenesis.
    Chung TW; Choi HJ; Park MJ; Choi HJ; Lee SO; Kim KJ; Kim CH; Hong C; Kim KH; Joo M; Ha KT
    Oncotarget; 2017 Jan; 8(3):4436-4448. PubMed ID: 28032600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse in vivo effects of soluble and membrane-bound M-CSF on tumor-associated macrophages in lymphoma xenograft model.
    Liao J; Feng W; Wang R; Ma S; Wang L; Yang X; Yang F; Lin Y; Ren Q; Zheng G
    Oncotarget; 2016 Jan; 7(2):1354-66. PubMed ID: 26595525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles.
    Zhu S; Niu M; O'Mary H; Cui Z
    Mol Pharm; 2013 Sep; 10(9):3525-30. PubMed ID: 23901887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.